Foghorn Therapeutics Inc. SEC filings FHTX

Foghorn Therapeutics Inc. has 354 filings in SEC EDGAR's recent list, going back to Aug 28, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (exit or restructuring costs, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
10-K Annual report Mar 11, 2026 Dec 31, 2025
ARS Annual report to shareholders May 5, 2025 Dec 31, 2024
10-K Annual report Mar 6, 2025 Dec 31, 2024
ARS Annual report to shareholders May 3, 2024 Dec 31, 2023
10-K Annual report Mar 7, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
10-K Annual report Mar 9, 2023 Dec 31, 2022
10-K/A Amended annual report Aug 9, 2022 Dec 31, 2021
10-K Annual report Mar 10, 2022 Dec 31, 2021
10-K/A Amended annual report Apr 29, 2021 Dec 31, 2020
10-K Annual report Mar 18, 2021 Dec 31, 2020

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
FHTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1822462

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.